The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls

BACKGROUND: Polycystic ovary syndrome (PCOS) is associated with obesity and increased cardiovascular (CV) risk markers. In this study our aim was to assess the effects of six months treatment with liraglutide 1.8 mg od on obesity, and CV risk markers, particularly platelet function, in young obese w...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Endocr Disord
Main Authors: Kahal, Hassan, Aburima, Ahmed, Ungvari, Tamas, Rigby, Alan S, Coady, Anne M, Vince, Rebecca V, Ajjan, Ramzi A, Kilpatrick, Eric S, Naseem, Khalid M, Atkin, Stephen L
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4389314/
https://ncbi.nlm.nih.gov/pubmed/25880805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-015-0005-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados